Joshua Hirsh, Thwe Htay, Shubhang Bhalla, Victoria Nguyen, Jorge Cervantes
{"title":"COVID-19免疫后SARS-CoV-2感染突破。","authors":"Joshua Hirsh, Thwe Htay, Shubhang Bhalla, Victoria Nguyen, Jorge Cervantes","doi":"10.1136/jim-2021-002131","DOIUrl":null,"url":null,"abstract":"<p><p>As no vaccines are 100% effective at preventing illness, COVID-19 vaccine breakthrough cases are expected. We here aim to review the most recent literature on COVID-19 vaccine breakthrough infections. SARS-CoV-2 breakthrough infections are, in general, rare. Age may still be a factor in SARS-CoV-2 infections in immunized individuals.</p>","PeriodicalId":520677,"journal":{"name":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research","volume":" ","pages":"1429-1432"},"PeriodicalIF":2.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Breakthrough SARS-CoV-2 infections after COVID-19 immunization.\",\"authors\":\"Joshua Hirsh, Thwe Htay, Shubhang Bhalla, Victoria Nguyen, Jorge Cervantes\",\"doi\":\"10.1136/jim-2021-002131\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>As no vaccines are 100% effective at preventing illness, COVID-19 vaccine breakthrough cases are expected. We here aim to review the most recent literature on COVID-19 vaccine breakthrough infections. SARS-CoV-2 breakthrough infections are, in general, rare. Age may still be a factor in SARS-CoV-2 infections in immunized individuals.</p>\",\"PeriodicalId\":520677,\"journal\":{\"name\":\"Journal of investigative medicine : the official publication of the American Federation for Clinical Research\",\"volume\":\" \",\"pages\":\"1429-1432\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2022-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of investigative medicine : the official publication of the American Federation for Clinical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/jim-2021-002131\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/6/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/jim-2021-002131","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Breakthrough SARS-CoV-2 infections after COVID-19 immunization.
As no vaccines are 100% effective at preventing illness, COVID-19 vaccine breakthrough cases are expected. We here aim to review the most recent literature on COVID-19 vaccine breakthrough infections. SARS-CoV-2 breakthrough infections are, in general, rare. Age may still be a factor in SARS-CoV-2 infections in immunized individuals.